Table 1. Baseline demographics.
|
Total (N=2,942) |
SFA (N=2,404) | PA (N=155) | SFA/PA (N=383) | p-value | |
|---|---|---|---|---|---|
| Age, years | 69.4±10.4 | 69.5±10.1 | 68.3±10.5 | 69.1±12.2 | 0.305 |
| Male | 2,397 (81.5) | 1,984 (82.5) | 121 (78.1) | 292 (76.2) | 0.007 |
| Body mass index, kg/m2 | 23.3±3.4 | 23.3±3.4 | 23.8±3.2 | 23.0±3.6 | 0.046 |
| Current smoker | 804 (27.3) | 675 (28.1) | 38 (24.5) | 91 (23.8) | 0.153 |
| Hypertension | 2,220 (75.5) | 1,831 (76.2) | 114 (73.5) | 275 (71.8) | 0.156 |
| Diabetes | 1,865 (63.4) | 1,524 (63.4) | 99 (63.9) | 242 (63.2) | 0.989 |
| Diabetes on insulin | 482 (16.4) | 403 (16.8) | 29 (18.7) | 50 (13.1) | 0.138 |
| Dyslipidaemia | 1,715 (58.3) | 1,398 (58.2) | 90 (58.1) | 227 (59.3) | 0.917 |
| Chronic kidney disease | 755 (25.7) | 595 (24.8) | 43 (27.7) | 117 (30.5) | 0.045 |
| End stage renal disease | 404 (13.7) | 306 (12.7) | 29 (18.7) | 69 (18.0) | 0.004 |
| Coronary artery disease | 1,385 (47.1) | 1,189 (49.5) | 53 (34.2) | 143 (37.3) | <0.001 |
| Chronic obstructive lung disease | 104 (3.5) | 92 (3.8) | 1 (0.6) | 11 (2.9) | 0.087 |
| Prior stroke | 515 (17.5) | 429 (17.8) | 28 (18.1) | 58 (15.1) | 0.426 |
| Prior endovascular therapy | 926 (31.5) | 735 (30.6) | 54 (34.8) | 137 (35.8) | 0.082 |
| Chronic limb-threatening ischaemia | 1,161 (39.5) | 888 (36.9) | 73 (47.1) | 200 (52.2) | <0.001 |
| TASC II type C or D | 1,675 (56.9) | 1,363 (56.7) | 64 (41.3) | 248 (64.8) | <0.001 |
| Lesion length ≥150 mm | 1,281 (43.5) | 1,048 (43.6) | 11 (7.1) | 222 (58.0) | <0.001 |
| Total occlusion | 1,480 (50.3) | 1,159 (48.2) | 83 (53.5) | 238 (62.1) | <0.001 |
| Moderate/severe calcification | 920 (31.3) | 743 (30.9) | 33 (21.3) | 144 (37.6) | 0.001 |
| Data are presented as mean±standard deviation or n (%). PA: popliteal artery; SFA: superficial femoral artery; TASC: TransAtlantic Inter-Society Consensus | |||||